SMN2 and proximal spinal muscular atrophy: The recent availability of an effective therapy is the culmination of more than two decades of research aimed at characterizing the molecular genetics underlying the disease following the discovery that SMA is caused by mutation or homozygous deletion of the survival motor neuron 1 (SMN1), a gene encoding the SMN protein.